They found that interactions between CD44 and MMP9 promoted the proteolytic activity of MMP9 against type IV of collagen, which correlated with cell invasiveness and enhanced tumor growth in vivo, and disruption of the CD44–MMP9 complex reduced the migratory potential of cancer cells [95]. The gene discussed is MMP9; the disease is neoplasm.